Want to see DHC full AI Analyst Report?
DHC Stock Chart & Stats
$8.08
-$0.04(-0.43%)
At close: 4:00 PM EDT
$8.08
-$0.04(-0.43%)
Day’s Range― - ―
52-Week Range$3.64 - $9.66
Previous CloseN/A
Volume424.99K
Average Volume (3M)1.65M
Market Cap
$1.83B
Enterprise Value$4.52K
Total Cash (Recent Filing)$116.79M
Total Debt (Recent Filing)$2.42B
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Nov 04, 2026EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend Yield0.52%
Share Statistics
EPS (TTM)-1.11
Shares Outstanding242,128,980
10 Day Avg. Volume1,112,333
30 Day Avg. Volume1,650,963
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.70
Price to Sales (P/S)0.76
P/FCF Ratio-59.40
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$10.17Price Target Upside25.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.62
Revenue Forecast (FY)$1.48B
Bulls Say, Bears Say
Bulls Say
SHOP Operating GrowthStrong senior housing operating growth, supported by higher occupancy and rates, can improve recurring NOI and strengthen DHC’s earnings base over the next several quarters as operator transitions mature.
Cost Savings And Margin ExpansionIdentified procurement and operating savings should support durable margin expansion across the senior housing portfolio, partially offsetting expense inflation and improving cash earnings as benefits become embedded.
Improved Liquidity And CoverageHigher liquidity and better leverage and interest coverage provide greater flexibility to fund property needs, manage maturities and pursue selective reinvestment, reducing near-term balance-sheet pressure.
Bears Say
Persistent Losses And Weak Cash GenerationOngoing bottom-line losses and negative absolute cash flow limit internal funding capacity, weaken shareholder returns and may keep DHC dependent on asset actions or external capital despite operating improvements.
Elevated Leverage And Refinancing ExposureAlthough leverage is moving in the right direction, the still-high debt burden can constrain capital allocation and leave DHC sensitive to operating setbacks or refinancing conditions as upcoming maturities approach.
Medical Office And Life Science Vacancy RiskThe upcoming vacancies create a multi-quarter leasing and cash-flow challenge in Medical Office and Life Science assets, potentially increasing downtime, tenant-improvement costs and pressure on segment NOI.
Diversified Healthcare Trust News
DHC FAQ
What was Diversified Healthcare Trust’s price range in the past 12 months?
Diversified Healthcare Trust lowest stock price was $3.64 and its highest was $9.66 in the past 12 months.
What is Diversified Healthcare Trust’s market cap?
Diversified Healthcare Trust’s market cap is $1.83B.
When is Diversified Healthcare Trust’s upcoming earnings report date?
Diversified Healthcare Trust’s upcoming earnings report date is Nov 04, 2026 which is in 62 days.
How were Diversified Healthcare Trust’s earnings last quarter?
Diversified Healthcare Trust released its earnings results on Aug 03, 2026. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.147 by -$0.013.
Is Diversified Healthcare Trust overvalued?
According to Wall Street analysts Diversified Healthcare Trust’s price is currently Undervalued.
Does Diversified Healthcare Trust pay dividends?
Diversified Healthcare Trust pays a Quarterly dividend of $0.01 which represents an annual dividend yield of 0.52%. See more information on Diversified Healthcare Trust dividends here
What is Diversified Healthcare Trust’s EPS estimate?
Diversified Healthcare Trust’s EPS estimate is -0.15.
How many shares outstanding does Diversified Healthcare Trust have?
Diversified Healthcare Trust has 242,128,980 shares outstanding.
What happened to Diversified Healthcare Trust’s price movement after its last earnings report?
Diversified Healthcare Trust reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.147. Following the earnings report the stock price went down -0.114%.
Which hedge fund is a major shareholder of Diversified Healthcare Trust?
Currently, no hedge funds are holding shares in DHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Diversified Healthcare Trust Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.17 (25.83% Upside)
$10.17 (25.83% Upside)
Blogger Sentiment
Bullish
DHC Sentiment 80%
Sector Average 58%
Sector Average 58%
Hedge Fund Trend
Decreased
By 79.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
101.58%
12-Months-Change
Fundamentals
Return on Equity
0.52%
Trailing 12-Months
Asset Growth
-10.88%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Diversified Healthcare Trust
Diversified Healthcare Trust (DHC) operates as a real estate investment trust (REIT) specializing in healthcare properties. Its extensive portfolio comprises medical office buildings, life science facilities, senior living communities, and wellness centers located across the United States. DHC's management is provided by an operating subsidiary of The RMR Group Inc., an alternative asset management company headquartered in Newton, Massachusetts.
DHC Company Deck
DHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a largely positive operational and financial picture driven by strong SHOP performance, meaningful NOI and margin expansion, improved liquidity and leverage metrics, and reaffirmed guidance. Key near-term headwinds include occupancy pacing below initial expectations due to timing of operator transitions, several one-time adjustments (benefits and charges), and known near-term vacancies in the Medical Office & Life Science segment. On balance, the operational momentum, cost savings, capital redeployment plans and guidance reaffirmation outweigh the temporary and identifiable headwinds.View all DHC earnings summariesDHC Stock 12 Month Forecast
Average Price Target
$10.17
▲(25.83% Upside)
Technical Analysis
Ownership Overview
10.19% Insiders
14.90% Mutual Funds
37.04% Other Institutional Investors
20.41% Public Companies and
Individual Investors